All News #Library
Others
J INTS BIO`s JIN-A02 Shows Tumor, Brain Metastasis Reductions In Phase 1
10 Jun 2024 //
PR NEWSWIRE
JINS BIO: Novel EGFR TKI JIN-A02 Shows Phase 1 Benefits
11 Apr 2024 //
PR NEWSWIRE
J INTS BIO Gives Presentation of Phase 1/2 study of `JIN-A02`
05 Dec 2023 //
PR NEWSWIRE
J INTS BIO, presentation of data of its Oral 4th Generation EGFR-TKI `JIN-A02`
15 Sep 2022 //
PRNEWSWIRE

Market Place
Sourcing Support